Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
April 18, 2014 | NPR · The agreement calls on all parties to refrain from violence, requires that illegally-armed groups disarm and that control of government buildings be returned to Ukrainian authorities.
 
April 18, 2014 | NPR · President Obama said enrollment under the Affordable Care Act reached 8 million after the deadline was extended by 2 weeks. The figure represents a turnaround from the disastrous debut of the website.
 
April 18, 2014 | NPR · Morning Edition spent a lot of time recently reporting from the U.S.-Mexico border. President Obama has deported 2 million people from the U.S. But many say that number is misleading.
 

Latest program rundown

Coming up:

Latest Features:
April 18, 2014 | NPR · It looks as though the "comment period" for the controversial Keystone XL pipeline project will be extended, delaying a decision past the November elections.
 
April 18, 2014 | NPR · Regular political commentators, E.J. Dionne of The Washington Post and David Brooks of The New York Times, discuss the breakthrough Ukraine deal and the new health care enrollment numbers.
 
UC Irvine Communications
April 18, 2014 | NPR · Ivan Soltesz studies epilepsy in mice, but says children with chronic seizures are his inspiration. He's closing in on a way to quell the seizures with light — and without drugs' side effects.
 

Latest Saturday rundown




WE Saturday Feature

April 19, 2014 | NPR · The search continues for hundreds of people, mostly students, who were on board a South Korean ferry when it sank this week. Correspondent Anthony Kuhn shares the latest with NPR's Wade Goodwyn.
 

Latest Sunday rundown


WE Sunday Feature

April 13, 2014 | NPR · As the anniversary of last year's marathon bombing approaches, NPR's Rachel Martin speaks with correspondent Carrie Johnson about the investigation and legal wrangling yet to come.
 

Latest program rundown

Coming up:

FDA

Apr 30, 2013 — Wrigley's new caffeinated gum has raised eyebrows at the FDA, which is worried about the potential health impacts on children and teens.
Comments |
Mar 5, 2012 — Public health officials will have a hard time convincing raw milk advocates that the product is dangerous, according to a new study.
Comments |
Feb 17, 2012 — With yet another outbreak of sprout-related illness, sprouts growers they need the FDA to provide new rules so they can test new techniques for reducing risk.
Comments |
Feb 16, 2012 — Many hospitals around the nation are perilously close to running out of a form of the old standby cancer drug methotrexate. The reason: a principal supplier of injectable methotrexate shut down in November after it flunked an FDA inspection.
Launch in player | Comments |
Feb 1, 2012 — Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.
Comments |
Sep 1, 2011 — Manufacturers of silicone breast implants have done such a poor job of tracking patients that it's impossible to know if the devices have long-term health and safety risks, consumer advocates said a meeting of experts advising the Food and Drug Administration.
Comments |
Aug 4, 2011 — The Food and Drug Administration has approved the first antivenom against scorpion toxin. Called Anascorp, the treatment was developed in Mexico and will cost more than $10,000 per patient. For small children, who are at greatest risk from the bites, the treatment can be life-saving.
Comments |
Jun 21, 2011 — The FDA's revamp of its anti-smoking campaign might make us a bit squeamish, but isn't that the point? The agency enlisted 18,000 people to help it pick the images that made people want to quit or never start smoking.
Launch in player | Comments |
May 27, 2011 — The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.
Comments |
more FDA from NPR